Actively hiring
Financial Services
Biologics & Biosimilars
Health Care
Infectious Disease Therapeutics
Oncology Therapeutics
Prescription Drugs
As featured in
View 2 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Merck and Ridgeback's Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization in the U.S. a
Read more
Report
Merck Statement on Ivermectin use During the COVID-19 Pandemic
KENILWORTH, N.J., Feb. 4, 2021 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of a
Read more
Report
Report
TRANSPARENCY AND PRIVACY
A key element in our approach to privacy at our company is our commitment to transparency in our privacy program. We aim to achieve this by providing clear and understandable notices of our privacy practices that enable our stakeholders to make meaningful
Read more
Report
Tech stack
Technologies named in job postings at Merck.com over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
3
Stack modernity
81/100AI adopter
Languages
Python
SQL
Cloud & platforms
GCP
Databricks
AI & ML
LLM
Practices & domains
Good Clinical Practice
Machine Learning
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$224k
Typical range
$184k – $300k
Open positions
3
3
Jobs
Junior
33.3%
Senior
33.3%
Architect
33.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $224k | $224k |
| Senior | 1 | $184k | $184k |
| Architect | 1 | $300k | $300k |
Highest paying role
Regional Medical Scientific Director (aka Medical Science Liaison) Immunology
$300k
Normalized to USD per year
People

David Johnson
Executive Officer, Director

Richard Vincent
Executive Officer

Langdon Miller
Executive Officer

Scott Karchmer
Executive Officer

Clayton Knox
Executive Officer

Michael Ross
Executive Officer

David Guyer
Executive Officer

Cam Gallagher
Director

Scott Glenn
Director

Min Cui
Director

Jayson Punwani
Director

Mark Chin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
79/100
Scaling fast
Open positions
3
2 opened / 0 closed in 30 days
Median time-to-fill
26 days
faster than 48% of the market
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Backend
20% ▲
Security
20% ▼
Leadership
20% ▲
Management
20% ▲
Science & Research
20% ▲
Activity Timeline
Added Microsoft Office to stack
Oct 2026
Added HIPAA to stack
Oct 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Diego
United States
HQ
Jobs
$117k – $184k per year • Hybrid • Full-Time • Rahway
Python
Git
Analytics
ETL/ELT
Life Sciences
Chromatography
LIMS
Apply
$191k – $300k per year • Remote (United States, Puerto Rico) • Full-Time
GCP
Cybersecurity
HIPAA
Life Sciences
Good Clinical Practice
Apply
Financials
Total raised
$210.5M
Latest round
Venture - Series Unknown
Funding rounds
5
